Adjuvant treatment with razoxane (ICRF 159) following resection of cancer of the stomach.
D004334:Drug Administration Schedule; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D011929:Razoxane / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery
D010879:Piperazines; D011929:Razoxane